The frustration is understandable.

To watch your team sit meekly by during one of the craziest, most active offseasons in recent memory can make a fanbase stir crazy. That holds especially true when you watch that same team lose pivotal pieces in free agency and not replace them.

Yes, the inactivity of the Baltimore Orioles can be maddening for some. It’s no fun not having a ticket to the coolest party of the offseason, especially when teams within your own division are some of the guests of honor.

Then again, when you run away with your division by 12 games and get back a couple of past All-Stars from injury and expect another to return to form, how much do you actually need to add, even if teams around you are getting a bit better?

The Orioles expect to have third baseman Manny Machado and catcher Matt Wieters back early in the season if not by Opening Day, and both have been All-Stars—Wieters made the American League squad last summer. The team also has high hopes that Chris Davis will return from his amphetamine suspension and get back to being something close to the hitter who posted a 168 OPS-plus—68 percent better than a league-average player—and finished third in MVP voting in 2013.

But it’s not like the O’s are doing nothing. General manager Dan Duquette has explored trades and kicked a lot of free-agent tires, but his most notable move of the offseason has been bringing back Delmon Young. There could be more to come very soon, though.

Manager Buck Showalter is expected to fly to Alabama to meet with outfielder Colby Rasmus over the next few days, The Baltimore Sun beat writer Eduardo A. Encina reported Wednesday. The reason for the meeting is for Showalter to determine if Rasmus, who has a spotty reputation, would be a good fit within the Orioles’ clubhouse. Showalter did the same thing last year with Nelson Cruz and Delmon Young, both players with off-the-field question marks at the time, and both were productive offensive additions en route to the team’s AL East title.

Because Cruz, who hit 40 home runs and had a 140 OPS-plus, is gone, as is right fielder Nick Markakis, the Orioles need outfield help. They are interested in Rasmus on a one-year deal worth between $6-8 million, according to Encina. If Rasmus can get back to the 127 OPS-plus he put up in 2013 with the Toronto Blue Jays, he would give Baltimore their second consecutive award for Steal of the Offseason, Cruz being the first.

Duquette also has interest in Ichiro Suzuki and Nori Aoki at more limited levels.

Also, only partly because the team lost left-hander Andrew Miller, the Orioles are still looking for bullpen help.

Even with this further exploration of outfield and bullpen options, the Orioles are operating as if time and rehab are their biggest offseason acquisitions. And maybe they are correct in that assessment.

Machado is a star on the rise and still just 22 years old. He suffered his second significant knee injury of his career last August the day the Orioles built a six-game lead in the division. He was done for the rest of the season, but the Orioles pushed the lead to as many as 14 games without him. At the time of the injury, Machado was arguably playing better than he did in 2013 when he was an All-Star, won a Gold Glove and finished ninth in MVP voting in his age 20-21 season.

Having him back and healthy is clearly a positive impact. However, the Orioles did much of what they did last season with Machado healthy. They missed him for only about a month and a half, plus the postseason. It’s not like they played all of 2014 minus Machado, so his comeback is definitely impactful, but not ground shaking.

Wieters is a different story. He suffered an elbow injury that required Tommy John surgery last June, although it kept him out of the lineup starting May 11. He was still voted as an All-Star starter, but the selection, while nice, was unwarranted despite him hitting .308/.339/.500 with a 135 OPS-plus through 26 games.

There have been questions about when Wieters could actually return, but his agent, Scott Boras, assured the baseball world his client would be ready for Opening Day. Position players undergoing Tommy John surgery usually are not lost for as long as pitchers who undergo the procedure. Having Wieters in the lineup for the start of the season would be a big addition for the Orioles, and it could help supplement the loss of Cruz if Wieters continues to progress offensively.

As for Davis, the Orioles had him for nearly an entire season before his suspension, and the only reason he was even an average player was because he managed to hit 26 home runs in 127 games. Aside from that, he hit .196/.300/.404 with a 98 OPS-plus and struck out 173 times against 60 walks.

The suspension was for Davis’ use of Adderall, a drug for which he previously had a therapeutic-use exemption. Davis failed to get one for 2014 and was suspended 25 games, which will keep him out of the Opening Day lineup this year as he has one more game to serve. Davis will have the TUE for 2015, and the Orioles are hoping his allowed use of Adderall will help get the former home run champ back to his 2013 form.

In an offseason filled with blockbuster trades, big-time free-agent signings and some improved rosters in the AL East, it can be maddening to watch the Orioles stand pat. But while the headlines might be going to the Boston Red Sox, New York Yankees and Toronto Blue Jays for their offseason moves, the truth is none of those teams have gotten that much better. They all still have holes and serious questions about their rosters.

Meanwhile, the Orioles are cruising through the winter, content with minor tweaks rather than huge overhauls because they expect their own players to be back healthy and productive come next spring. And that just may be enough for their repeat performance in 2015.

Anthony Witrado covers Major League Baseball for Bleacher Report. He spent the previous three seasons as the national baseball columnist at Sporting News, and four years before that as the Brewers beat writer for the Milwaukee Journal Sentinel. Follow Anthony on Twitter @awitrado and talk baseball here.

Read more MLB news on BleacherReport.com